Jason O’Byrne
Förmögenhet: 359 944 $ per 2026-05-31
Förmögenhet: 359 944 $ per 2026-05-31
Jason V.
O’Byrne is currently Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. since 2024.
Formerly, Mr. O’Byrne was Chief Financial & Accounting Officer at Caribou Biosciences, Inc. from 2021 to 2024, Senior Vice President-Finance at Astellas Gene Therapies, Inc. from 2019 to 2021, Regional Controller at General Chemical Corp.
from 2002 to 2005, and Regional Head-Commercial Finance APAC at Genentech, Inc. Education includes an undergraduate degree from the University of British Columbia and an MBA from The Leonard N Stern School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC. 0,02 % | 2026-03-31 | 37 730 ( 0,02 % ) | 359 944 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Finansdirektör/CFO | 2024-10-02 |
| Företag | Position | Slut |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Finansdirektör/CFO | 2024-09-27 |
| AUDENTES THERAPEUTICS, INC. | Finansdirektör/CFO | 2021-02-01 |
General Chemical Corp.
General Chemical Corp. Industrial SpecialtiesProcess Industries Manufactures and supplies metal lubricant products | Företagsledare/Principal | 2005-01-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
General Chemical Corp.
General Chemical Corp. Industrial SpecialtiesProcess Industries Manufactures and supplies metal lubricant products | Process Industries |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån